DVAXSMALL

Dynavax Technologies Corporation

HealthcareDrug Manufacturers - Specialty & Generic
$15.50
$0.00(+0.00%)
52W$9.20
$15.73
Updated May 7, 12:00 AM
RSI76
RS Rating89/99
Beta0.75
Volatility54%
F-Score6/9
Mkt Cap$1.8B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Dynavax Technologies Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 89), indicating clear outperformance against the broad market. Earnings growth of 91% provides fundamental context to the price action. However, with RSI at 76, the stock is extended and may be prone to a short-term pullback.

Relative Strength
89
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.75
vs S&P 500
DEFENSIVE
52W Position
96%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$14.03
50 SMA > 100 SMA$12.23
100 SMA > 150 SMA$11.65
150 SMA > 200 SMA$11.28

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$15.54-0.23%BELOW
50 SMA$14.03+10.45%ABOVE
100 SMA$12.23+26.69%ABOVE
150 SMA$11.65+33.00%ABOVE
200 SMA$11.28+37.39%ABOVE

Price Performance

1D+0.0%
1W
1M
3M+0.0%
6M+41.0%
YTD+0.8%
1Y+41.9%
3Y+12.4%
52-Week Trading Range96% from low
$15.50
52W Low$9.20
52W High$15.73

Technical Indicators

RSI (14)OVERBOUGHT
75.7
305070
VCP ScoreWARM
6/10
Base depth: 32.9%

Risk Profile

Beta
0.75
52W Vol
54%
ATR
$0.05
Max DD (1Y)
-18%

Volume Analysis

Today
5.66M
50D Avg
5.66M
Vol Ratio
1.00x
Liquidity
MODERATE

Earnings Momentum

Q4'24+2781%
$0.05
Q1'25-1049%
$-0.77
Q2'25+71%
$0.14
Q3'25+91%
$0.21
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+38.05%
5 Years:+51.08%
3 Years:-14.23%
TTM:+26.73%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:-29.47%
TTM:-395.34%

Stock Price CAGR

10 Years:+0.96%
5 Years:+11.79%
3 Years:+12.42%
1 Year:+41.94%

Return on Equity

10Y Avg:-86.4%
5Y Avg:-18.7%
3Y Avg:25.5%
Last Year:-8.1%

Key Metrics

Market Cap$1.8B
Gross Margin82.2%
Net Margin9.9%
Piotroski F-Score6/9

Frequently Asked Questions

Is DVAX in an uptrend right now?

DVAX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, DVAX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is DVAX overbought or oversold?

DVAX's RSI (14) is 76. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is DVAX outperforming the market?

DVAX has a Relative Strength (RS) Rating of 89 out of 99. Yes, DVAX is a market leader, outperforming 89% of all stocks over the past 12 months.

Where is DVAX in its 52-week range?

DVAX is trading at $15.50, which is 99% of its 52-week high ($15.73) and 96% above its 52-week low ($9.20).

How volatile is DVAX?

DVAX has a Beta of 0.75 and 52-week volatility of 54%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.